Hypoxia-inducible factor HIF-1α: pharmacogenetic perspective for bevacizumab therapy individualization

被引：0

作者：

Tauser, Roxana-Georgiana ^{[1
]}

Zugun-Eloae, Florin ^{[2
]}

Jitaru, Daniela ^{[3
]}

Carasevici, Eugen ^{[2
]}

机构：

[1] Gr T Popa Univ Med & Pharm Iasi, Dept Med Chem, Sch Pharm, Iasi 700115, Romania

[2] Gr T Popa Univ Med & Pharm Iasi, Sch Med, Dept Immunol, Iasi 700115, Romania

[3] St Spiridon Univ Emmergency Hosp Iasi, Iasi, Romania

来源：

REVISTA ROMANA DE MEDICINA DE LABORATOR | 2009年 / 16卷 / 03期

关键词：

pharmacogenetics; bevacizumab; hypoxia inducible factor; cancer; CIRCULATING ENDOTHELIAL-CELLS; METASTATIC COLORECTAL-CANCER; BREAST-CANCER; POLYMORPHISMS; ANGIOGENESIS; CHALLENGES; FLUOROURACIL; CHEMOTHERAPY; LEUCOVORIN; GENE;

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Pharmacogenetics of innovative angiogenic-targeted monoclonal antibody therapy, yet in its infancy, will be crucial in treatment individualization according to the genetic profile of each patient and molecular features of tumors. Bevacizumab (Avastin) specifically targets the key promotor of angiogenesis - vascular endothelial growth factor (VEGF), whose transcription is critically regulated by hypoxia-inducible factor HIF-1 alpha. The present paper points out the clinical relevance of HIF-1 alpha common genetic polymorphisms to the inter-individual variability in response to anti-VEGF-targeted monoclonal antibody therapeutic regimens, with special reference to colorectal cancer.

引用

页码：7 / 12

页数：6

共 50 条

[31] ROLES FOR HYPOXIA-INDUCIBLE FACTOR-1 (HIF-1) IN BRAIN PROTECTION AND PLASTICITY
Jones, N. M.
JOURNAL OF NEUROCHEMISTRY, 2010, 115 : 12 - 12
[32] Glucose requirement for hypoxic accumulation of hypoxia-inducible factor-1α (HIF-1α)
Vordermark, D
Kraft, P
Katzer, A
Bölling, T
Willner, J
Flentje, M
CANCER LETTERS, 2005, 230 (01) : 122 - 133
[33] Role of hypoxia-inducible factor-1 (HIF-1) is angiogenesis and tumour biology
Ratcliffe, PJ
JOURNAL OF VASCULAR RESEARCH, 1999, 36 (02) : 160 - 160
[34] Role of Hypoxia-inducible factor-1? (HIF-1?) in Intramembranous Bone Regeneration
Lee, Hoomin
Huh, Yun Suk
Ko, Frank
JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 310 - 310
[35] Pathogenesis of diabetic nephropathy: Role of hypoxia-inducible factor-1a(HIF-1α)
Haneda, Masakazu
Makino, Yuichi
Takiyama, Yumi
ENDOCRINE JOURNAL, 2010, 57 : S219 - S219
[36] Selection and analysis of a mutant cell line defective in the hypoxia-inducible factor-1 α-subunit (HIF-1α) -: Characterization of HIF-1α-dependent and -independent hypoxia-inducible GENE expression
Wood, SM
Wiesener, MS
Yeates, KM
Okada, N
Pugh, CW
Maxwell, PH
Ratcliffe, PJ
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (14) : 8360 - 8368
[37] Zinc induces the accumulation of hypoxia-inducible factor (HIF)-1α, but inhibits the nuclear translocation of HIF-1β, causing HIF-1 inactivation
Chun, YS
Choi, E
Kim, GT
Lee, MJ
Lee, MJ
Lee, SE
Kim, MS
Park, JW
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 268 (02) : 652 - 656
[38] Inducible expression of hypoxia-inducible factor 1α (HIF-1α) as a tool for studying HIF-1α-dependent gene regulation during normoxia in vitro
Meissner, U
Allabauer, I
Repp, R
Rascher, W
Dötsch, J
PHARMACOLOGY, 2003, 69 (02) : 74 - 78
[39] Hypoxia-inducible factor 1-α (HIF-1α) and hypoxia-inducible factor 2-α (HIF-2α) expression, angiogenesis and relationship to prognosis in rectal cancer patients
Rasheed, S
Harris, AL
Tekkis, PP
Turley, H
Silver, A
Johnson, V
McDonald, PJ
Talbot, IC
Glynne-Jones, R
Northover, JM
Guenther, T
DISEASES OF THE COLON & RECTUM, 2006, 49 (05) : 719 - 720
[40] Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1α
Elkins, JM
Hewitson, KS
McNeill, LA
Seibel, JF
Schlemminger, I
Pugh, CW
Ratcliffe, PJ
Schofield, CJ
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) : 1802 - 1806

← 1 2 3 4 5 →